Jump to content Jump to main menu Jump to sub menu

Latest News

16 January 2012 - QED Sponsor PharmaTimes Clinical Researcher of the Year Awards

QED is proud to announce that we will be sponsoring the Pharmaceutical Project Manager category at the upcoming PharmaTimes Clinical Researcher of the Year awards.  The awards ceremony will take place on the 16th February in London.  QED already has two of its own Project Managers shortlisted as finalists in the CRO Project Manager category.  For more information, please visit: http://www.pharmatimes.com/Competitions/ClinicalResearcher.aspx

13 October 2011 - QED invited to present at Henry Stewart’s SOP Conference

QED’s Director of UK Operations, Susan Ollier, will present at the Henry Stewart’s SOP conference on 7th November in London.  Susan has been invited to speak at this annual event, at the opening session, on Regulatory requirements around SOPs.  For more information and to take advantage of QED preferential booking rates for the conference, please visit: www.eventrsuite.com/henrystewartsops/eu2011  or contact us directly.

15 April 2011 - QED win international CNS trial

QED are delighted to announce that they have been selected for an international observational study in Parkinson’s Disease.  The study will run for 5 years and QED will be responsible for sites in the UK, Italy, Germany and Austria.  QED’s Director International Operations, Nazira Maruf said “We are extremely pleased to be involved in this project which is helping to combat this progressive neurological condition.  Our expertise on the ground in each of the participating countries, coupled with our central expertise will ensure we can deliver this trial successfully”.

21 September 2011 - QED receives 2 Finalist nominations in the PharmaTimes Awards 2011, Project Management Category

QED is proud to announce that two of its Clinical Study Managers have been shortlisted as Finalists in the PharmaTimes Awards 2011 CRO Project Management Cateogory.  QED’s CEO, Thomas Ogorka, commented; “We are absolutely delighted that the strength of our project management expertise has been acknowledged and adds further recognition to QED’s efforts to drive best practice and quality in all areas of clinical research”.  The final assessment will take place on the 17th November 2011, where the finalists will present to the competition judges, with the awards ceremony taking place in February 2012.  For more information, please visit: http://www.pharmatimes.com/Competitions/ClinicalResearcher/Finalists.aspx

10 March 2011 - QED expands Observational study experience

QED is pleased to announce that it has further extended it’s Observational study experience with the award of an important project in Chronic Obstructive Pulmonary Disease.  The study will run in the UK for 18 months.  Susan Ollier, QED Director UK Operations, commented “We are delighted to be selected for this study, which enhances both our Observational trial and Respiratory therapeutic area expertise”.

« Previous Entries
Next Page »